Fazila Seker is passionate about women’s health and social disparity issues within health care. She is the CEO and Co-founder of MOLLI Surgical, a company that develops devices to guide precision surgeries for a better patient experience. She has over twenty years of experience in business venture development, commercial leadership and market strategy in the medical device, energy and specialty materials industries as Program Leader for GE Global Research Center in Niskayuna, NY and Director of Technology and Venture Development for MaRS Innovation in Toronto, Canada. At GE, she created and launched the corporate Nanotechnology program. During her tenure, she successfully generated $10 million in growth funding and was recognized with the GE Management Award for exceptional leadership.
August 19, 2022 — The Christ Hospital Health Network, known for providing the best, most compassionate care for its community, is the first in Ohio to adopt Molli Surgical’s wire-free and radiation-free breast cancer localization technology:
Like ourselves, the team at The Christ Hospital Health Network is dedicated to reimagining what healthcare can be and truly understanding patient-first care. We are committed to helping them create more efficiencies in their radiology and surgery departments and deliver exceptional outcomes and experiences for their patients.